{"meta":{"query_hash":"b216c0b14cd8","filters":{"venue":"The Korean Journal of Health Economics and Policy"},"cohort_total":1,"direct_labels_cover":0,"predictions_cover":1,"exported":1,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/b216c0b14cd8","api":"https://metacan.xera.ac/api/v1/cohort?venue=The+Korean+Journal+of+Health+Economics+and+Policy"},"results":[{"id":"W2967469332","doi":"","title":"Review of reimbursement recommendations of the oncology and the orphan drug in Korea, Australia, Canada and Britain","year":2014,"lang":"en","type":"article","venue":"The Korean Journal of Health Economics and Policy","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Orphan drug; Reimbursement; Medicine; Family medicine; Drug approval; Drug; Economic growth; Economics; Pharmacology; Health care; Bioinformatics","score_opus":0.18768222132768558,"score_gpt":0.4332463151104734,"score_spread":0.24556409378278782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967469332","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00429282,0.9016405,0.00043396128,0.07928614,0.003484012,0.00013923069,0.0013143115,0.000021979235,0.009387112],"genre_scores_gemma":[0.073658355,0.87205213,0.0033974696,0.04358604,0.003029066,0.00021274299,0.0013003696,0.000044013672,0.0027198375],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.98582274,0.0042707413,0.0030216745,0.0005880194,0.005523618,0.0007732392],"domain_scores_gemma":[0.9346499,0.03351554,0.0072058397,0.00052136416,0.022280794,0.001826586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02344062,0.0005727076,0.0020820047,0.007941299,0.0011322028,0.0044655832,0.0029566798,0.003873361,0.0043674777],"category_scores_gemma":[0.08523409,0.0006098008,0.0022346994,0.010243685,0.0015026118,0.0016190005,0.0011613988,0.0040456653,0.00037435442],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009494996,0.00010974685,0.0073857945,0.05341237,0.001747085,0.0004693497,0.0009818258,0.0025916516,0.00031438336,0.02958162,0.38813943,0.51431733],"study_design_scores_gemma":[0.0004211623,0.00012619051,0.039077923,0.14025061,0.0037475994,0.00043605804,0.0012993551,0.0010820186,0.00026597417,0.0045051724,0.80865216,0.00013583271],"about_ca_topic_score_codex":0.2210087,"about_ca_topic_score_gemma":0.36490747,"teacher_disagreement_score":0.9773004,"about_ca_system_score_codex":0.02269961,"about_ca_system_score_gemma":0.05478071,"threshold_uncertainty_score":0.4394446},"labels":[],"label_agreement":null}]}